Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (DFPH) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to $35.6 million.

  • Oncology Institute's Accounts Payables rose 4501.87% to $35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.6 million, marking a year-over-year increase of 4501.87%. This contributed to the annual value of $24.3 million for FY2024, which is 6857.72% up from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Accounts Payables is $35.6 million, which was up 4501.87% from $34.9 million recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Accounts Payables registered a high of $35.6 million during Q3 2025, and its lowest value of $24707.0 during Q1 2021.
  • For the 5-year period, Oncology Institute's Accounts Payables averaged around $15.9 million, with its median value being $13.9 million (2022).
  • Over the last 5 years, Oncology Institute's Accounts Payables had its largest YoY gain of 7221632.81% in 2021, and its largest YoY loss of 9142.88% in 2021.
  • Quarter analysis of 5 years shows Oncology Institute's Accounts Payables stood at $15.6 million in 2021, then tumbled by 39.76% to $9.4 million in 2022, then surged by 53.96% to $14.4 million in 2023, then soared by 68.58% to $24.3 million in 2024, then surged by 46.5% to $35.6 million in 2025.
  • Its Accounts Payables stands at $35.6 million for Q3 2025, versus $34.9 million for Q2 2025 and $29.3 million for Q1 2025.